References
Aubourg P., Adamsbaum C., Lavallard Rousseau M. C., et al. (1993) A two-year trial of oleic and erucic acids ("Lorenzo’s oil") as treatment for adrenomyeloneuropathy. N. Engl. J. Med. 329, 745–752.
Edwin D., Speedie L. J., Köhler W., et al. (1996) Cognitive and brain magnetic resonance imaging findings in adrenomyeloneuropathy. Ann. Neurol. 40, 675–678.
Gärtner J., Braun A., Holzinger A., et al. (1998) Clinical and genetic aspects of X-linked adrenoleukodystrophy. Neuropediatrics 29, 3–13.
Kaplan P. W., Tusa R. J., Shankroff J., et al. (1993) Visual evoked potentials in adrenoleukodystrophy: A trial with glycerol trioleate and Lorenzo oil. Ann. Neurol. 34, 169–174.
Kok F., Neumann S., Sarde C. O., et al. (1995) Mutational analysis of patients with X-linked adrenoleukodystrophy. Hum. Mutat. 6, 104–115.
Korenke G. C., Hunneman D. H., Köhler J., et al. (1995) Glyceroltrioleate/glyceroltrierucate therapy in 16 patients with X-chromosomal adrenoleukodystrophy/adrenomyeloneuropathy: effect on clinical, biochemical and neurophysiological parameters. Eur. J. Pediatr. 154, 64–70.
Kumar A. J., Köhler W., Kruse B., et al. (1995) MR findings in adult-onset adrenoleukodystrophy. Am. J. Neuroradiol. 16, 1227–1237.
Kurtzke J. F. (1970) Neurologic impairment in multiple sclerosis and the disability Status Scale. Acta. Neurol. Scand. 46, 493–512.
Loes D. J., Hite S., Moser H., et al. (1994) Adrenoleukody-strophy: A scoring method for brain MR observations. Am. J. Neuroradiology 15, 1761–1766.
Moser H. W. (1997) Adrenoleukodystrophy: Phenotype, genetics, pathogenesis and therapy. Brain 120, 1485–1508.
Moser H. W. and Moser A. B. (1989) Adrenoleukodystrophy (X-linked), in The Metabolic Bases of Inherited Disease, 6th ed. (Scriver C. R., Beaudet A. L., Sly W. S., et al., eds.), McGraw Hill, New York, pp. 1511–1532.
Moser H. W., Köhler W., Borel J., et al. (1995) The many faces of X-linked adrenoleukodystrophy: Implications for pathogenesis and the evaluation of therapy, in Functions and Biogenesis of Peroxisomes in Relation to Human Disease (Wanders R. J. A., Schutgens R. B. H., Tabak H. F., eds.), North-Holland, Amsterdam, pp. 227–246.
Singh I., Kahn M., Key L., et al. (1998) Lovastatin for X-linked adrenoleukodystrophy. N. Engl. J. Med. 339, 702,703.
Uziel G., Bertini E., Bardelli P., et al. (1991) Experience on therapy of adrenoleukodystrophy and adrenomyeloneuropathy. Dev. Neurosci. 13, 274–279.
References
van der Knaap M.S. and Valk J. (1995) Magnetic Resonance of Myelin, Myelination and Myelin Disorders, 2nd ed. Springer, Heidelberg.
van der Knaap M. S., Valk J., de Neeling N., and Nauta J. J. P. (1991) Pattern recognition in magnetic resonance imaging of white matter disorders in children and young adults. Neuroradiology 33, 478–493.
References
Aubourg P., Sellier N., Chaussain J. L., and Kalifa G. (1989) MRI detects cerebral involvement in neurologically asymptomatic patients with adrenoleukodystrophy. neurology 39, 1619–1621.
Basser P. J. and Pierpaoli C. (1996) Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J. Magn. Reson. B. 111, 209–219.
Basser P. J., Mattiello J., and LeBihan D. (1994a) Estimation of the effective self-diffusion tensor from the NMR spin echo. J. Magn. Reson. B. 103, 247–254.
Basser P. J., Mattiello J., and LeBihan D. (1994b) MR diffusion tensor spectroscopy and imaging. Biophys. J. 66, 259–267.
Beaulieu C. and Allen P.S. (1994) Water diffusion in the giant axon of the squid: Implications for diffusion-weighted MRI of the nervous system. Magn. Reson. Med. 32, 579–583.
Carr H. Y. and Purcell H. Y. (1954) Effects of diffusion on free precession in nuclear magnetic resonance experiments. Phys. Rev. 94, 630–638.
Chun T., Ulug A. M., and van Zijl P. C. M. (1998) Single-shot diffusion-weighted trace imaging on a clinical scanner. Magn. Reson. Med. 40, 622–628.
Hajnal J. V., Bydder G. M., and Young I. R. (1994) Use of fluid attenuated inversion recovery sequence in magnetic resonance imaging [letter; comment]. Lancet 344, 8939,8940.
Kruse B., Barker P. B., van Zijl P. C., Duyn J. H., Moonen C. T., and Moser H. W. (1994) Multislice proton magnetic resonance spectroscopic imaging in X-linked adrenoleukodystrophy. Ann. Neurol. 36, 595–608.
Le Bihan D., Breton E., and Lallemand D. (1986) MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 161, 401–407.
Makris N., Worth A. J., Sorensen A. G., Papadimitriou G. M., Wu 0., Reese T. G., et al. (1997) Morphometry of in vivo human white matter association pathways with diffusion-weighted magnetic resonance imaging. Ann. Neurol. 42, 951–962.
Melhem E. R., Breiter S. N., Ulug A. M., Raymond G. V., and Moser H. W. (1996) Improved tissue characterization in adrenoleukodystrophy using magnetization transfer imaging. Am. J. Roentgenol. 166, 689–695.
Moonen C. T., Pekar J., deVleeschouwer MH, van Gelderen P., van Zijl P. C., and DesPres D. (1991) Restricted and anisotropic displacement of water in healthy cat brain and in stroke studied by NMR diffusion imaging. Magn. Reson. Med. 19, 327–332.
Mori S. and van Zijl P. C. M. (1995) Diffusion weighting by the trace of the diffusion tensor within a single scan. Magn. Reson. Med. 33, 41–52.
Mori S., Crain B. J., Chacko V. P., and van Zijl P. C. M. Three-dimensional tracking of axonal projections in the brain by magnetic resonance imaging. Ann. Neurol. (in press).
Moseley M. E., Cohen Y., Kucharczyk J., Mintorovitch J., Asgari H. S., Wendland M. F., et al. (1990) Diffusion-weighted MR imaging of anisotropic water diffusion in cat central nervous system. Radiology 176, 439–445.
Pierpaoli C., Jezzard P., Basser P. J., Bamett A., and Di Chiro G. (1996) Diffusion tensor MR imaging of the human brain. Radiology 201, 637–648.
Pierpaoli C., Choi B., Schiffmann R., and Di Chiro G. (1997) Diffusion tensor MRI in Pelizaeus-Merzbacher disease [abstract], in Book of ISMRM, 5th Scientific Meeting Vancouver, B.C., p. 664.
Stejskal E. O. and Tanner J. E. (1965) Spin diffusion measurements: Spin echoes in the presence of a time-dependent field gradient. J. Chem. Phys. 42, 288–292.
Ulug A. M. and van Zijl P. C. M. (1997) Orientation-independent diffusion tensor imaging of the human brain. J. Mag. Reson. I.
Wimberger D. M., Roberts T. P., Barkovich A. J., Prayer L. M., Moseley M. E., and Kucharczyk J. (1995) Identification of “premyelination” by diffusion-weighted MRI. J. Comput. Assist. Tomogr. 19, 28–33.
Wolff S. D. and Balaban R. S. (1994) Magnetization transfer imaging: Practical aspects and clinical applications. Radiology 192, 593–599.
References
Cady E. B., Dawson M. J., Hope P. L., Tofts P. S., de Costello A. M., Delpy D. T., et al. (1983) Non-invasive investigation of cerebral metabolism in newborn infants by phosphorus nuclear magnetic resonance spectroscopy. Lancet 1, 1059.
Confort-Gouny S., Vion-Dury J., Chabrol B., Nicoli F., and Cozzone P.J. (1995) Localized proton magnetic resonance spectroscopy in X-linked adrenoleukodystrophy. Neuroradiology 37, 568.
Ernst T., Kreis R., and Ross B. D. (1993) Absolute quantitation of water and metabolites in the human brain. Part I: compartments and water. J. Magn. Reson. 102, 1.
Kreis R., Ernst T., and Ross B. D. (1993) Absolute quantitation of water and metabolites in the human brain. Part II: metabolite concentrations. J. Magn. Reson. 102, 9.
Tzika A. A., Ball W. S., Vigneron D. B., Dunn R. S., Nelson S. J., and Kirks D. R. (1993) Childhood adrenoleukodystrophy: assessment with proton MR spectroscopy. Radiology 189, 467.
References
Bluml S., McComb J. G., and Ross B. D. (1997) Differentiation between cortical atrophy and hydrocephalus using 1H MRS. Magn. Reson. Med. 37, 395–403.
Kreis R., Ernst T., and Ross B. D. (1993a) Absolute quantitation of water and metabolites in the human brain. Part II: Metabolite concentrations. J. Magn. Reson. 102, 9–19.
Kreis R., Ernst T., and Ross B. D. (1993b) Development of the human brain: In vivo quantification of metabolite and water content with proton MRS. Magn Reson. Med. 30, 424–437.
Tan J., Bluml S., Hoang T., Dubowitz D., Mevenkamp G., and Ross B. (1998) Lack of effect of oral choline supplement of the concentrations of choline metabolites in human brain. Magn. Reson. Med. 39.
van der Knaap M. S., van der Grond J., van Rijen P. C., Faber J. A. J., Valk J., and Willemse K. (1990) Age-dependent changes in localized proton and phosphorus MR spectroscopy of the brain. Radiology 176, 509–513.
References
Giesser B. S., Kurtzberg D., Vaughan H. G., Arezzo J. C., Aisen M. L., Smith C. R., et al. (1987) Trimodal evoked potentials compared with magnetic resonance imaging in the diagnosis of Multiple Scelerosis. Arch. Neurol. 44, 281–284.
Honig L. S., Ramsay R. E., and Sheremata W. A. (1992) Eventrelated potential P300 in Multiple Sclerosis: Relation to magnetic resonance imaging and cognitive impairment. Arch. Neurol. 49, 44–50.
Molfese D. L. and Molfese V. J. (1997) Discrimination of language skills at five years of age using event-related potentials recorded at birth. Dev. Neuropsychology 13(2), 135–156.
Nuwer M. R., Packwood J. W., Myers L. W., and Ellison G. W. (1987) Evoked potentials predict the clinical changes in a multiple sclerosis drug study. Neurology 37, 1754–1761.
Slater J. D., Wu F. Y., Honig L. S., Ramsay R. E., and Morgan R. (1994) Neural network analysis of the P300 event-related potential in multiple sclerosis. Electroencephalogr. Clin. Neurophysiol. 90, 114–122.
References
Aubourg P., Blanche S., Jambaque I., et al. (1990) Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by BM Tation. N. Engl. J. Med. 322, 1860–1866.
Gärtner J., Braun A., Holzinger A., et al. (1998) Clinical and genetic aspects of X-linked adrenoleukodystrophy. Neuropediatrics 29, 3–13.
Krivit W., Lockman L. A., Watkins P. A., Hirsch J., and Shapiro E. G. (1995) The future for treatment by bone marrow transplantation for adrenoleukodystrophy, metachromatic leukodystrophy, globoid cell leukodystrophy and Hurler syndrome. J. Inherited Metab. Dis. 18, 398–412.
Lilford R. J., Thomton J. G., and Braunholtz D. (1995) Clinical trials and rare diseases: a way out of a conundrum. Br. Med. J. 311, 1621–1625.
Shapiro E. G., Lockman L. A., Balthazor M., and Krivit W. (1995) Neuropsychological outcomes of several storage diseases with and without BMTation. J. Inherited Metab. Dis. 18, 413–419.
References
Cohen P. J. (1998) The placebo is not dead: three historical vignettes. IRB: a Rev. Hum. Subjects Res. 20, 6–8.
Fetting J. H., Siminoff L. A., Piantadosi S., Abeloff M. D., Damron D. J., and Sarsfield A. M. (1990) Effect of patients’ expectations of benefit with standard breast cancer adjuvant chemotherapy on participation in a randomized clinical trial: a clinical vignette study. J. Clin. Oncol. 8(9), 1476–1482.
Kass N., Sugarman J., Faden R., and Schoch-Spana M. (1996) Trust: the fragile foundation of contemporary biomedical research. The Hastings Center Report 26, 25–29.
Rajagopal S., Goodman P. J., and Tannuck I. F. (1994) Adjuvant chemotherapy for breast cancer: discordance between physicians’ perception of benefit and the results of clinical trials. J. Clin. Oncol. 12(6), 1296–1304.
National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, “The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research.” April 18, 1979.
Rights and permissions
About this article
Cite this article
Moser, H.W. B. Evaluation techniques. J Mol Neurosci 13, 247–267 (1999). https://doi.org/10.1385/JMN:13:3:247
Issue Date:
DOI: https://doi.org/10.1385/JMN:13:3:247